The European Union could raise its funding contribution from the €200 million spent so far to €1 billion in the next phase of the European and Developing Countries Clinical Trials Partnership (EDCTP).
The offer is conditional on approval of the European Commission’s budget proposals for 2014-20 and on funding commitments made by other parties, including EU Member States, African countries, industry and charities.
It was made by Research, Innovation and Science Commissioner Máire Geoghegan Quinn at a conference in Cape Town, South Africa, on the second EDCTP programme. The next phase begins in 2014, in parallel with the EU’s new programme for research and innovation, Horizon 2020. Read more